It has been previously shown that suppression of HO-1 expression can impede the proliferation and viability of pancreatic cancer cells [70], as well as the survival and growth of hepatocellular carcinoma [71] and prostate cancer cells [72]. This evidence concerns the gene HMOX1 and pancreatic neoplasm.